Susquehanna International Group’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Other funds holding KZR
BCM
SCM
TCM
VCM
RC
AAA
PLC
Susquehanna International Group's KZR Position: Q4 2024 in Review
Susquehanna International Group sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 1,259 shares — an estimated $9.38K sold.
Susquehanna International Group first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $1.1M in Q1 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.
- Susquehanna International Group reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
- Susquehanna International Group sold 1,259 Kezar Life Sciences shares in Q4 2024, an estimated $9.38K.
- Susquehanna International Group first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
- Susquehanna International Group's Kezar Life Sciences position peaked at $1.1M in Q1 2022.
- 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.